Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatrics

Diagnosis & Genetics: How pSLE is Identified

At a Glance

Pediatric lupus (pSLE) is diagnosed using standardized criteria that evaluate symptoms alongside blood tests like ANA. Children diagnosed before age five or with atypical symptoms often undergo genetic testing to check for rare single-gene mutations driving the disease.

Diagnosing pediatric systemic lupus erythematosus (pSLE) is rarely a straightforward process. Because the disease often begins with mild, nonspecific symptoms, there is frequently a delay between the first signs of illness and a formal diagnosis [1]. To help doctors navigate this complexity, they use standardized sets of “rules” called classification criteria.

Understanding Diagnostic Criteria

Doctors primarily use two sets of criteria to determine if a child has lupus. These were originally designed for adults, but they are highly effective for children as well:

  • SLICC 2012 Criteria: This set is known for its high sensitivity, meaning it is very good at “catching” cases of lupus even when symptoms are early or atypical [2].
  • EULAR/ACR 2019 Criteria: These are the most current guidelines and are considered the most appropriate for pSLE today [3]. They require a positive ANA (antinuclear antibody) test as an “entry” point and then use a weighted point system to balance accuracy (not missing a case) with precision (not misdiagnosing another condition) [4][5].

The Role of Genetic Testing

While most lupus cases are caused by a mix of genetics and environment, some pediatric cases are monogenic—driven primarily by a single gene mutation. Genetic testing is particularly valuable in specific scenarios [6]:

  • Very Early-Onset: Children diagnosed before age 5 have a much higher likelihood of an underlying genetic cause [1][6].
  • Atypical Presentations: When a child has symptoms that don’t fit the usual pattern or has a strong family history of early-onset autoimmunity.
  • Specific Mutations: Testing can identify deficiencies in proteins like C1Q or mutations in genes like UNC93B1 [7]. In children with UNC93B1 variants, the immune system becomes “hyper-responsive,” reacting too strongly to signals that it should ignore [8][9].

If a monogenic form of lupus is suspected, your medical team may recommend consulting a genetic counselor to discuss whether siblings should be tested or monitored.

Evaluating Kidney Health: The Renal Biopsy

One of the most critical steps in the pSLE work-up is checking the health of the kidneys, as 50% to 80% of children with lupus develop kidney involvement [10].

Doctors will carefully monitor blood and urine tests. They look closely at complement proteins (C3 or C4) in the blood, as low levels can be an early clue of “silent” inflammation happening in the organs [11].

If clinical indicators suggest kidney involvement (such as protein in the urine, active urine sediment, or a rising creatinine level), a renal biopsy becomes essential to determine the type and severity of inflammation [11]. This procedure involves taking a tiny sample of kidney tissue, typically performed with a small needle under ultrasound guidance while the child is sedated or asleep, ensuring they do not feel pain.

Why Diagnosis Can Be Delayed

For the majority of children, pSLE has a “mild” start [1]. Because the symptoms—like fatigue, growing pains, or a faint rash—can look like many other childhood issues, it often takes months to reach the right specialist. Only a small number of children present with severe, multi-organ disease from day one that leads to a rapid diagnosis [1]. If you feel your child’s symptoms are being overlooked, knowing these criteria can help you advocate for more specialized testing.

Common questions in this guide

How do doctors diagnose pediatric lupus?
Doctors use standardized diagnostic rules, such as the EULAR/ACR 2019 criteria. These guidelines require a positive ANA blood test and then use a point system based on specific symptoms and lab results to confirm the diagnosis accurately.
Should my child get genetic testing for lupus?
Genetic testing is highly recommended if a child is diagnosed before age five, has atypical symptoms, or has a strong family history of autoimmune disease. Testing can identify rare monogenic forms of lupus driven by a single gene mutation.
Why might my child need a kidney biopsy?
Up to 80 percent of children with pSLE develop kidney involvement. If blood or urine tests show signs of kidney inflammation, a biopsy is performed to determine the exact type and severity of the damage, which guides treatment decisions.
What does it mean if my child's C3 or C4 complement levels are low?
Low levels of complement proteins, such as C3 or C4, can be an early warning sign of silent inflammation in the organs. Doctors monitor these closely to catch potential kidney involvement before more severe symptoms appear.
Why does a pediatric lupus diagnosis often take so long?
Early symptoms of pediatric lupus, such as fatigue, minor rashes, or growing pains, are very common in many mild childhood illnesses. Because it rarely starts with severe, multi-organ disease, it often takes time for the specific pattern of lupus to emerge and be recognized.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many points does my child score on the EULAR/ACR 2019 criteria, and which symptoms contributed most to the diagnosis?
  2. 2.Do my child's blood and urine tests suggest any kidney involvement that would warrant a renal biopsy?
  3. 3.Given my child's age at diagnosis, is genetic testing for mutations like C1Q or UNC93B1 appropriate for us?
  4. 4.Should our family consult a genetic counselor or have our other children tested based on these findings?
  5. 5.Were my child's complement (C3 and C4) levels low at diagnosis, and what does that tell us about their risk for silent inflammation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study.

    Novak GV, Molinari BC, Ferreira JC, et al.

    Lupus 2018; (27(10)):1712-1717 doi:10.1177/0961203318787037.

    PMID: 30020023
  2. 2

    Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus.

    Rodrigues Fonseca A, Felix Rodrigues MC, Sztajnbok FR, et al.

    Advances in rheumatology (London, England) 2019; (59(1)):20 doi:10.1186/s42358-019-0062-z.

    PMID: 31092290
  3. 3

    Evaluating the Applicability of the EULAR/ACR 2019, SLICC 2012, and ACR 1997 Classification Criteria for Systemic Lupus Erythematosus in Children: A Multicenter Study.

    Qiao J, Ma Y, Zhang X, et al.

    The Journal of rheumatology 2026; (53(6)):679-685 doi:10.3899/jrheum.2025-0559.

    PMID: 41397864
  4. 4

    EULAR/ACR classification criteria for SLE.

    Aringer M

    Seminars in arthritis and rheumatism 2019; (49(3S)):S14-S17 doi:10.1016/j.semarthrit.2019.09.009.

    PMID: 31779843
  5. 5

    Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al.

    Zapata L, Chong BF

    Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(8)):1403 doi:10.1002/art.41296.

    PMID: 32336046
  6. 6

    Genetic landscape of early-onset systemic lupus erythematous in India.

    Sharma M, Pilania RK, Volpi S, et al.

    Rheumatology (Oxford, England) 2026; (65(6)) doi:10.1093/rheumatology/keaf631.

    PMID: 42251732
  7. 7

    Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus.

    Al-Azab M, Idiiatullina E, Liu Z, et al.

    Nature immunology 2024; (25(6)):969-980 doi:10.1038/s41590-024-01846-5.

    PMID: 38831104
  8. 8

    UNCovering new causes of monogenic systemic lupus erythematosus.

    Ellyard JI, Gantier MP

    Immunology and cell biology 2024; (102(8)):651-654 doi:10.1111/imcb.12807.

    PMID: 38981619
  9. 9

    Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.

    David C, Arango-Franco CA, Badonyi M, et al.

    The Journal of experimental medicine 2024; (221(8)) doi:10.1084/jem.20232066.

    PMID: 38869500
  10. 10

    Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.

    Smith EMD, Aggarwal A, Ainsworth J, et al.

    Annals of the rheumatic diseases 2023; (82(6)):788-798 doi:10.1136/ard-2022-223328.

    PMID: 36627168
  11. 11

    Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.

    Wakiguchi H, Takei S, Kubota T, et al.

    Clinical rheumatology 2017; (36(2)):433-437 doi:10.1007/s10067-016-3491-7.

    PMID: 27900491

This page explains pSLE diagnostic criteria and genetics for educational purposes only. Always consult your pediatric rheumatologist or genetic counselor for formal diagnosis and testing decisions.

Get notified when new evidence is published on Pediatric systemic lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.